Yesterday BGI agreed to acquire Complete Genomics for about $120 million to expand in the U.S. market for medical and research DNA testing.Complete Genomics’s sequencing technology gives results slower than that of Illumina, however comparative studies have shown that the technology BGI is acquiring is more accurate than Illumina’s. The purchase may also reduce BGI’s dependence on sequencer-maker Illumina.
More details about the takeover at Bloomberg Businessweek.
No comments:
Post a Comment